Literature DB >> 20233654

Misdirected opposition: Evidence opposing "not in my back yard" arguments against syringe exchange programmes.

Chyvette T Williams1, Lawrence J Ouellet.   

Abstract

BACKGROUND: Despite overwhelming evidence of their effectiveness, the establishment and maintenance of syringe exchange programmes (SEPs) in the US continue to draw opposition from community members, religious and political leaders, and law enforcement officials. One argument against SEPs is that they draw drug activity into the communities where they operate.
METHODS: We use 8 years of survey data from participants attending an SEP in Chicago to explore this argument by reviewing responses (N=4827) to a question asking participants the main reason they spend time in the area.
RESULTS: Findings show far more participants come to the area to buy drugs (60%) than to exchange needles (3.8%), and differences exist by ethnicity. More whites than blacks or Latinos reported being in the area primarily to buy drugs and use the SEP.
CONCLUSION: Re-directing opposition from SEPs to constructive ways of addressing fundamental causes of drug markets is recommended. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20233654     DOI: 10.1016/j.drugpo.2010.02.003

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  3 in total

1.  Needle exchange and the geography of survival in the South Bronx.

Authors:  Katherine McLean
Journal:  Int J Drug Policy       Date:  2012-03-13

2.  Students as effective harm reductionists and needle exchange organizers.

Authors:  Kyle Barbour; Miriam McQuade; Brandon Brown
Journal:  Subst Abuse Treat Prev Policy       Date:  2017-03-17

3.  Syringe service program-based telemedicine linkage to opioid use disorder treatment: protocol for the STAMINA randomized control trial.

Authors:  Dennis P Watson; James A Swartz; Lisa Robison-Taylor; Mary Ellen Mackesy-Amiti; Kim Erwin; Nicole Gastala; Antonio D Jimenez; Monte D Staton; Sarah Messmer
Journal:  BMC Public Health       Date:  2021-03-31       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.